Kabat Database and its applications: future directions
Open Access
- 1 January 2001
- journal article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 29 (1) , 205-206
- https://doi.org/10.1093/nar/29.1.205
Abstract
The Kabat Database was initially started in 1970 to determine the combining site of antibodies based on the available amino acid sequences. The precise delineation of complementarity determining regions (CDR) of both light and heavy chains provides the first example of how properly aligned sequences can be used to derive structural and functional information of biological macromolecules. This knowledge has subsequently been applied to the construction of artificial antibodies with prescribed specificities, and to many other studies. The Kabat database now includes nucleotide sequences, sequences of T cell receptors for antigens (TCR), major histocompatibility complex (MHC) class I and II molecules, and other proteins of immunological interest. While new sequences are continually added into this database, we have undertaken the task of developing more analytical methods to study the information content of this collection of aligned sequences. New examples of analysis will be illustrated on a yearly basis. The Kabat Database and its applications are freely available at http://immuno.bme.nwu.edu.Keywords
This publication has 6 references indexed in Scilit:
- Kabat Database and its applications: 30 years after the first variability plotNucleic Acids Research, 2000
- EVOLUTION OF ANTIGEN BINDING RECEPTORSAnnual Review of Immunology, 1999
- Antibodies of sharks: revolution and evolutionImmunological Reviews, 1998
- A method of estimating the numbers of human and mouse T cell receptors for antigen α and β chain V‐genesImmunology & Cell Biology, 1997
- Somatic hyperconversion diversifies the single VH gene of the chicken with a high incidence in the D regionCell, 1989
- AN ANALYSIS OF THE SEQUENCES OF THE VARIABLE REGIONS OF BENCE JONES PROTEINS AND MYELOMA LIGHT CHAINS AND THEIR IMPLICATIONS FOR ANTIBODY COMPLEMENTARITYThe Journal of Experimental Medicine, 1970